MDMA

kite fly sky blue sky flying
Biotech

AtaiBeckley's MDMA drug improves anxiety in ph. 2 trial

The trial was the first to assess R-MDMA in patients with social anxiety disorder, AtaiBeckley CEO Srinivas Rao said in a statement.
Will Maddox Feb 26, 2026 1:32pm
Graphic image of someone overwhelmed and with brain discomfort or headaches

Transcend links MDMA analog to PTSD improvements in phase 2

Mar 31, 2025 8:00am
FDA

Lykos still plotting path to approval for rejected MDMA therapy

Jan 17, 2025 9:00am
FDA stop sign

Lykos accepts FDA view that MDMA med needs new trial for approval

Oct 21, 2024 8:31am
dominoes domino

After FDA rejection and layoffs, Lykos' CEO is leaving

Sep 5, 2024 1:39pm
In Laboratory Over the Shoulder View of Scientist in Protective Clothes Doing Research on a Personal Computer

PharmAla launches tool aimed at easing access to MDMA drug info

Aug 28, 2024 12:55pm